Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Burles Johnson MD

Burles Johnson MD

Instructor of Oncology, Johns Hopkins University, Baltimore, Maryland

Dr. Johnson is an Instructor of Oncology at Johns Hopkins University. He treats patients with genitourinary malignancies, particularly bladder cancer. His research is focused on the role of B cells in bladder cancer, as well as sex based differences in immunity that drive different outcomes in bladder cancer. He has received an ASCO Young Investigator Award, an AACR-BMS Fellowship for Young Investigators in Translational Immuno-oncology, and a Bladder Cancer Advocacy Network New Discoveries Young Investigator Award.

Disclosures

Dr. Johnson serves on an advisory board for Seattle Genetics, and is a co-author on a pending patent for the use of immune based gene signatures as predictive biomarkers for ICI response.

Recent Contributions to PracticeUpdate:

  1. Biomarker Analysis for Survival Prediction With Avelumab Maintenance in Advanced Urothelial Carcinoma

Recently Updated